Talks (15-17 minutes + 3-5 minutes for Q&A)

Farrah Kheradmand, MD, Baylor College of Medicine
The Role of MAGE-A4 in Immune Modulation and Lung Cancer Progression

Chris Geyer, PhD, East Carolina University
The Germ Cell-Specific RNA Binding Protein RBM46 Is a Potential Cancer-Testis Antigen that Regulates the Mitosis-to-Meiosis Switch

Li Lan, MD, PhD, Duke University
Rewiring Meiosis: A Survival Strategy in Cancer

Julie V. Decock, PhD, Qatar Biomedical Research Institute
From Cancer Metabolism to Therapeutic Targeting: Decoding the Role of LDHC

Clinical Application Talks (15-17 minutes + 3-5 minutes for Q&A)

Matthew Sun, MD, UT-Southwestern Medical Center
Targeting NY-ESO-1 in Meningiomas

Cassian Yee, MD, MD Anderson Cancer Center
Deja Immunity: CT Antigens Make a Comeback

Flash Talks (3-4 minutes + 1-2 minutes for Q&A)

Elena Pugacheva, PhD; NIH/NIAID
Cancer-Testis Antigen CTCFL/BORIS Epigenetically Reprograms CTCF Sites into Alternative Promoters

Yang Fan, PhD, UT-Southwestern Medical Center
P53 Loss Triggers Germline Expression Programs

Michael Klutstein, PhD, Hebrew University of Jerusalem
The Cancer Epi-Metabolite L-2-Hydroxyglutarate Regulates Meiotic Centromere and Heterochromatin Conformation

Anne Hamacher-Brady, PhD, Johns Hopkins University
A Cancer/Testis Antigen as a Mitochondrial Hyperfusion Factor: The Case of FATE1

Nuria Cortes Silva, PhD, UT-Southwestern Medical Center
The Cancer Testis Antigen Actl8 Is a Novel Nuclear Actin-Related Protein That Alters Gene Expression